"gamma-Aminobutyric Acid" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The most common inhibitory neurotransmitter in the central nervous system.
| Descriptor ID |
D005680
|
| MeSH Number(s) |
D02.241.081.114.500.350 D12.125.190.350
|
| Concept/Terms |
gamma-Aminobutyric Acid- gamma-Aminobutyric Acid
- gamma Aminobutyric Acid
- GABA
- Aminalon
- Aminalone
- 4-Aminobutanoic Acid
- 4 Aminobutanoic Acid
- 4-Aminobutyric Acid
- 4 Aminobutyric Acid
|
Below are MeSH descriptors whose meaning is more general than "gamma-Aminobutyric Acid".
Below are MeSH descriptors whose meaning is more specific than "gamma-Aminobutyric Acid".
This graph shows the total number of publications written about "gamma-Aminobutyric Acid" by people in this website by year, and whether "gamma-Aminobutyric Acid" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 0 | 2 | 2 |
| 1996 | 2 | 0 | 2 |
| 1997 | 0 | 1 | 1 |
| 2003 | 0 | 1 | 1 |
| 2004 | 1 | 0 | 1 |
| 2005 | 0 | 2 | 2 |
| 2006 | 0 | 4 | 4 |
| 2007 | 1 | 2 | 3 |
| 2008 | 0 | 2 | 2 |
| 2009 | 1 | 3 | 4 |
| 2010 | 3 | 2 | 5 |
| 2011 | 2 | 2 | 4 |
| 2012 | 2 | 0 | 2 |
| 2013 | 1 | 2 | 3 |
| 2014 | 4 | 1 | 5 |
| 2015 | 1 | 3 | 4 |
| 2016 | 1 | 2 | 3 |
| 2017 | 1 | 0 | 1 |
| 2018 | 1 | 0 | 1 |
| 2019 | 1 | 0 | 1 |
| 2020 | 0 | 2 | 2 |
| 2021 | 1 | 0 | 1 |
| 2022 | 0 | 1 | 1 |
| 2023 | 0 | 3 | 3 |
To return to the timeline,
click here.
Below are the most recent publications written about "gamma-Aminobutyric Acid" by people in Profiles.
-
Ceol CJ. Microenvironmental GABA Signaling Regulates Melanomagenesis through Reciprocal Melanoma-Keratinocyte Communication. Cancer Discov. 2023 10 05; 13(10):2128-2130.
-
Patton AP, Morris EL, McManus D, Wang H, Li Y, Chin JW, Hastings MH. Astrocytic control of extracellular GABA drives circadian timekeeping in the suprachiasmatic nucleus. Proc Natl Acad Sci U S A. 2023 05 23; 120(21):e2301330120.
-
Deligiannidis KM, Clayton AH. Patient-Specific Considerations, the GABA Pathway, and New Clinical Trial Data on Neuroactive Steroids in MDD and PPD. J Clin Psychiatry. 2023 03 16; 84(Suppl 1).
-
Ferrari LL, Ogbeide-Latario OE, Gompf HS, Anaclet C. Validation of DREADD agonists and administration route in a murine model of sleep enhancement. J Neurosci Methods. 2022 Oct 01; 380:109679.
-
Tu J, Jin Y, Zhuo J, Cao X, Liu G, Du H, Liu L, Wang J, Xiao H. Exogenous GABA improves the antioxidant and anti-aging ability of silkworm (Bombyx mori). Food Chem. 2022 Jul 30; 383:132400.
-
Sueviriyapan N, Granados-Fuentes D, Simon T, Herzog ED, Henson MA. Modelling the functional roles of synaptic and extra-synaptic ?-aminobutyric acid receptor dynamics in circadian timekeeping. J R Soc Interface. 2021 09; 18(182):20210454.
-
Ma Z, Freeman MR. TrpML-mediated astrocyte microdomain Ca2+ transients regulate astrocyte-tracheal interactions. Elife. 2020 12 07; 9.
-
Benson KL, Bottary R, Schoerning L, Baer L, Gonenc A, Eric Jensen J, Winkelman JW. 1H MRS Measurement of Cortical GABA and Glutamate in Primary Insomnia and Major Depressive Disorder: Relationship to Sleep Quality and Depression Severity. J Affect Disord. 2020 09 01; 274:624-631.
-
Lapane KL, Hume AL, Morrison RA, Jesdale BM. Prescription analgesia and adjuvant use by pain severity at admission among nursing home residents with non-malignant pain. Eur J Clin Pharmacol. 2020 Jul; 76(7):1021-1028.
-
Venner A, Mochizuki T, De Luca R, Anaclet C, Scammell TE, Saper CB, Arrigoni E, Fuller PM. Reassessing the Role of Histaminergic Tuberomammillary Neurons in Arousal Control. J Neurosci. 2019 11 06; 39(45):8929-8939.